PEG-Intron, a longer-acting form of Intron-A for treating hepatitis C
Schering is now introducing PEG-Intron, a longer-acting form of Intron-A for treating hepatitis C.
PEG-Intron is the first "pegylated" interferon.
It's made by linking polyethylene glycol (PEG) to Intron-A (interferon alfa-2b). PEG slows the metabolism of the interferon and makes it longer-acting.
Get concise advice on drug therapy, plus unlimited access to CE
Pharmacist's Letter includes:
- 12 issues every year, with brief articles about new meds and hot topics
- 200+ CE courses, including the popular CE-in-the-Letter
- Quick reference drug comparison charts
- Access to the entire archive
Already a subscriber? Log in
Volume pricing available. Get a quote